4 hrs ago | P&T Community
Multiple Sclerosis Drug Fails Phase III Trial
A pivotal phase III study of arbaclofen placarbil for the treatment of patients with spasticity due to multiple sclerosis was unsuccessful in demonstrating that the drug provided statistically significant improvement compared with placebo in the trial's co-primary endpoints.
5 unique and outside-the-box multiple sclerosis researched therapies
Multiple sclerosis , a neurological disease that affects millions of people all across the world, harms everyone who has this disease is such unbelievable ways and, as of yet, finding a cure has proved incredibly allusive.
XenoPort to drop multiple sclerosis drug after trial failure
XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition significantly compared with a placebo.
Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started
In this video, health-care analyst David Williamson discusses why Biogen Idec 's party may just be getting started despite a huge run in the stock already.
'Only cannabis spray relieves my MS - so why won't the NHS give it to ...
'Only cannabis spray relieves my MS - so why won't the NHS give it to me?' Sufferer refused drug to help ease affects of disease Mr Rudd was refused Sativex on the NHS while sufferers living a few miles away are being prescribed the cannabis spray The drug hasn't been assessed by the National Institute for Health and Clinical Excellence - meaning ... (more)
Walk MS brings together people of all walks of life for the common goal of curing the nervous system disease.
A charity supporter is aiming to travel 101 miles along the South Downs Way on his mobility scooter.
A charity supporter is aiming to raise A 10,000 for charity - by travelling 101 miles along the South Downs Way on his mobility scooter.
Young scientists shine in AZ competition
It is the largest high school science competition in the world and it's happening right here in the Valley.
Study identifies new approach to improving treatment for MS and other conditions
Working with lab mice models of multiple sclerosis , UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS.
Scientists successfully create human stem cells through cloning
The feat, which has been attempted without success for almost two decades, could lead to new treatments for diseases like Parkinson's and multiple sclerosis.
Hamilton motorcyclist refuses to let multiple sclerosis slow him down
Mike Pawelczak has had MS for over 30 years and leads a group of motorcycle riders, who provide support for cyclists.
Research and Markets: Laquinimod (Multiple Sclerosis) - Forecast and Market Analysis to 2022
Teva's and Active Biotech's laquinimod is a synthetic, once-daily, orally-administered immunomodulator under investigation for the treatment of RRMS.
A multiple sclerosis sufferer from North Finchley has raised nearly 5000 for charity.
Paula Sanchez, 23, who was diagnosed with the condition five months ago, gathered together celebrities and cake lovers to raise money for the Multiple Scleroisis Society during an event at the Hyatt Regency Hotel last month.
Mersey 10k runner Kelly needs you to boost MS Society funds
A WIRRAL woman will take part in the Mersey Tunnel 10k to help fund research into multiple sclerosis after her mum was diagnosed with the condition.
OHSU cloning technique could help patients with Parkinson's, diabetes, multiple sclerosis
Oregon researchers have successfully produced human embryonic stem cells using a new technique that could eventually offer hope for conditions such as Parkinson's disease.
Campath slash Lemtrada for relapsing-remitting multiple sclerosis
Campath was chemotherapy medication used in the fighting of chronic lymphocytic leukemia and was used as an off-brand, chemotherapy-type therapy for helping those with multiple sclerosis as well.
OAS Wednesday - Activating immunity to suppress autoimmunity.
Every time I see an ad for some remedy that "Helps BOOST the Immune System!" I die a little inside.
MS Walk in Corning raises $55K
On a picture-perfect spring morning, 467 people took part in Sunday's, May 5, MS Walk in downtown Corning, raising an estimated $55,000. The event was a fundraiser for the National MS Society Upstate New York Chapter.
A north Iowa woman is looking to raise awareness as she takes part in the Walk MS event this weekend.
Opexa Therapeutics Reports First Quarter 2013 Financial Results and Provides Corporate Update
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Opexa Therapeutics, Inc.